Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
BioMatrix And Highmark Announce Settlement | ||
By: PR Newswire Association LLC. - 12 Feb 2019 | Back to overview list |
|
WESTON, Fla. and PITTSBURGH, Feb. 12, 2019 /PRNewswire/ -- BioMatrix Specialty Pharmacy and Highmark, Inc. jointly announced today that they have settled litigation pending between the two companies. This agreement enables both companies to focus on their respective commitments to providing high quality care for patients with chronic medical conditions. To ensure continuity of care, BioMatrix and Highmark will continue to service patients who live in Pennsylvania, Delaware, and West Virginia. "We are pleased to have reached this mutual settlement and commend Highmark for its enduring commitment to care for people with hemophilia and other chronic conditions," Nicholas Karalis, BioMatrix's interim COO and founder of Elwyn Pharmacy Group, said. "We look forward to working with Highmark to build a partnership that will drive the best possible outcomes for our mutual patients." Aaron Bilger, VP Internal & External Communications at Highmark Health said: "We are thankful that, as a result of this agreement, specialty medications BioMatrix provides will be widely available across our network." About BioMatrix Specialty Pharmacy About Highmark Inc. Contacts: For BioMatrix: Tara Marchese, Corporate Director of Marketing, 954-908-7636 For Highmark: Aaron Bilger, VP Media/Communications, 412-544-7826
View original content:http://www.prnewswire.com/news-releases/biomatrix-and-highmark-announce-settlement-300794385.html SOURCE BioMatrix Specialty Pharmacy |
||
|
||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |